FDA Approves Unknown Drug — NANG KUANG PHARM CO

# FDA Approves Generic Drug Application for NANG KUANG PHARM CO The FDA has approved ANDA 204329 for Nang Kuang Pharm Co, expanding the company's generic drug portfolio and positioning it to capture additional market share in the competitive generic pharmaceuticals sector. The approval enables the manufacturer to bring a cost-effective therapeutic option to market, potentially increasing competition and driving price reductions for patients and healthcare systems.